Rhode Island 2023 Regular Session

Rhode Island House Bill H5922 Compare Versions

Only one version of the bill is available at this time.

Old	New	Differences
1	1
2	2
3	3
4	4
5	5	2023 -- H 5922
6	6	========
7	7	LC002079
8	8	========
9	9	S TATE OF RHODE IS LAND
10	10	IN GENERAL ASSEMBLY
11	11	JANUARY SESSION, A.D. 2023
12	12	____________
13	13
14	14	A N A C T
15	15	RELATING TO FOOD AND DRUGS -- UNIFORM CONTROLLED SUBSTANCE S ACT
16	16	Introduced By: Representatives Hull, Phillips, Diaz, Noret, DeSimone, Fogarty, Abney,
17	17	and Biah
18	18	Date Introduced: March 01, 2023
19	19	Referred To: House Judiciary
20	20	(Attorney General)
21	21
22	22	It is enacted by the General Assembly as follows:
23	23	SECTION 1. Section 21-28-2.08 of the General Laws in Chapter 21-28 entitled "Uniform 1
24	24	Controlled Substances Act" is hereby amended to read as follows: 2
25	25	21-28-2.08. Contents of schedules. 3
26	26	Schedules I through V shall consist of the drugs and other substances, by whatever official 4
27	27	name, common or usual name, chemical name, or brand name designated, listed in the 5
28	28	corresponding section, or designated by the director of the department of health pursuant to § 21-6
29	29	28-2.01. 7
30	30	Schedule I 8
31	31	(a) Schedule I shall consist of the drugs and other substances, by whatever official name, 9
32	32	common or usual name, chemical name, or brand name designated, listed in this section. 10
33	33	(b) Opiates. Unless specifically excepted or unless listed in another schedule, any of the 11
34	34	following opiates, including its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers 12
35	35	whenever the existence of the isomers, esters, ethers, and salts is possible within the specific 13
36	36	chemical designation: 14
37	37	(1) Acetylmethadol 15
38	38	(2) Allylprodine 16
39	39	(3) Alphacetylmethadol 17
40	40	(4) Alphameprodine 18
41	41	(5) Alphamethadol 19
42	42
43	43
44	44	LC002079 - Page 2 of 18
45	45	(6) Benzethidine 1
46	46	(7) Betacetylmethadol 2
47	47	(8) Betameprodine 3
48	48	(9) Betamethadol 4
49	49	(10) Betaprodine 5
50	50	(11) Clonitazene 6
51	51	(12) Dextromoramide 7
52	52	(13) Difenoxin 8
53	53	(14) Diampromide 9
54	54	(15) Diethylthiambutene 10
55	55	(16) Dimenoxadol 11
56	56	(17) Dimepheptanol 12
57	57	(18) Dimethylthiambutene 13
58	58	(19) Dioxaphetyl butyrate 14
59	59	(20) Dipipanone 15
60	60	(21) Ethylmethylthiambutene 16
61	61	(22) Etonitazene 17
62	62	(23) Extoxerdine 18
63	63	(24) Furethidine 19
64	64	(25) Hydroxypethidine 20
65	65	(26) Ketobemidone 21
66	66	(27) Levomoramide 22
67	67	(28) Levophenacylmorphan 23
68	68	(29) Morpheridine 24
69	69	(30) Noracymethadol 25
70	70	(31) Norlevorphanol 26
71	71	(32) Normethadone 27
72	72	(33) Norpipanone 28
73	73	(34) Phenadoxone 29
74	74	(35) Phenampromide 30
75	75	(36) Phenomorphan 31
76	76	(37) Phenoperidine 32
77	77	(38) Piritramide 33
78	78	(39) Proheptazine 34
79	79
80	80
81	81	LC002079 - Page 3 of 18
82	82	(40) Properidine 1
83	83	(41) Propiram 2
84	84	(42) Racemoramide 3
85	85	(43) Trimeperidone 4
86	86	(44) Tilidine 5
87	87	(45) Alpha-methylfentanyl 6
88	88	(46) Beta-hydroxy-3-methylfentanyl other names: 7
89	89	N-[1-(2hydroxy-2-phenethyl)-3-methyl-4piperidingyl]-Nphenylpropanamide 8
90	90	(47) Alpha-methylthiofentanyl (N-[1-methyl-2-(2-thienyl)ethyl-4-piperidinyl]-N-9
91	91	phenylpropanamide) 10
92	92	(48) N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide, its optical, positional, and 11
93	93	geometric isomers, salts and salts of isomers (Other names: acetyl fentanyl) 12
94	94	(49) N-[1-[2-hydroxy-2-(thiophen-2-yl)ethyl]piperidin-4-yl]-N-phenyl propionamide 13
95	95	(Other names: beta-hydroxythiofentanyl) 14
96	96	(50) N-(1-phenethylpiperidin-4-yl)-N-phenylbutyramide (Other names: Butyryl fentanyl) 15
97	97	(51) N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-2-carboxamide (Other names: Furanyl 16
98	98	fentanyl) 17
99	99	(52) 3,4-dichloro-N-[(1-dimethylamino) cyclohexylmethyl]benzamide (Other names: AH-18
100	100	7921) 19
101	101	(53) 3,4-Dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide (Other names: 20
102	102	U-47700) 21
103	103	(54) 3-Methylbutyrfentanyl (Other names: 3-MBF) 22
104	104	(55) 4-Fluorobutyrfentanyl (Other names: 4-FBF, p-FBF) 23
105	105	(56) 4-Phenylfentanyl 24
106	106	(57) 4-Methoxybutyrfentanyl (Other names: 4-MeO-BF) 25
107	107	(58) Acrylfentanyl (Other names: acryloyfentanyl) 26
108	108	(59) Lofentanyl 27
109	109	(60) N-Methylcarfentanyl 28
110	110	(61) Ocfentanyl (INN, A-3217) 29
111	111	(63) 4-methoxymethylfentanyl (Other names: R-30490) 30
112	112	(64) 1-cyclohexyl-4-(1,2 diphenylethyl)piperazine) (Other names: MT-45, IC-6) 31
113	113	(c)(b) Opium Derivatives. Unless specifically excepted or unless listed in another schedule, 32
114	114	any of the following opium derivatives, its salts, isomers, and salts of isomers whenever the 33
115	115	existence of the salts, isomers, and salts of isomers is possible within the specific chemical 34
116	116
117	117
118	118	LC002079 - Page 4 of 18
119	119	designation: 1
120	120	(1) Acetorphine 2
121	121	(2) Acetyldihydrocodeine 3
122	122	(3) Benzylmorphine 4
123	123	(4) Codeine methylbromide 5
124	124	(5) Codeine-N-Oxide 6
125	125	(6) Cyprenorphine 7
126	126	(7) Desomorphine 8
127	127	(8) Dihydromorphine 9
128	128	(9) Etorphine (Except hydrochloride salt) 10
129	129	(10) Heroin 11
130	130	(11) Hydromorphinol 12
131	131	(12) Methyldesorphine 13
132	132	(13) Methylihydromorphine 14
133	133	(14) Morphine methylbromide 15
134	134	(15) Morphine methylsulfonate 16
135	135	(16) Morphine-N-Oxide 17
136	136	(17) Myrophine 18
137	137	(18) Nococodeine 19
138	138	(19) Nicomorphine 20
139	139	(20) Normorphine 21
140	140	(21) Pholcodine 22
141	141	(22) Thebacon 23
142	142	(23) Drotebanol 24
143	143	(d)(c) Hallucinogenic Substances. Unless specifically excepted or unless listed in another 25
144	144	schedule, any material, compound, mixture, or preparation that contains any quantity of the 26
145	145	following hallucinogenic substances, or that contains any of its salts, isomers, and salts of isomers 27
146	146	whenever the existence of the salts, isomers, and salts of isomers is possible within the specific 28
147	147	chemical designation (for purposes of this subsection only, the term “isomer” includes the optical, 29
148	148	position, and geometric isomers): 30
149	149	(1) 3, 4-methylenedioxy amphetamine 31
150	150	(2) 5-methoxy-3, 4-methylenedioxy amphetamine 32
151	151	(3) 3, 4, 5-trimethoxy amphetamine 33
152	152	(4) Bufotenine 34
153	153
154	154
155	155	LC002079 - Page 5 of 18
156	156	(5) Diethyltryptamine 1
157	157	(6) Dimethyltryptamine 2
158	158	(7) 4-methyl 2, 5-dimethoxyamphetamine 3
159	159	(8) Ibogaine 4
160	160	(9) Lysergic acid diethylamide 5
161	161	(10) Marihuana 6
162	162	(11) Mescaline 7
163	163	(12) Peyote. Meaning all parts of the plant presently classified botanically as Lophophora 8
164	164	Williamsii Lemair whether growing or not; the seeds of the plant; any extract from any part of the 9
165	165	plant; and any compound, manufacture, salt, derivative, mixture, or preparation of the plant, its 10
166	166	seeds or extracts. 11
167	167	(13) N-ethyl-3-piperidyl benzilate 12
168	168	(14) N-methyl-3-piperidyl benzilate 13
169	169	(15) Psilocybin 14
170	170	(16) Psilocyn 15
171	171	(17) Tetrahydrocannabinols. Synthetic equivalents of the substances contained in the plant, 16
172	172	or in the resinous extractives of Cannabis, sp. and/or synthetic substances, derivatives, and their 17
173	173	isomers with similar chemical structure and pharmacological activity such as the following: delta 18
174	174	1 cis or trans tetrahydrocannabinol, and their optical isomers. Delta 6 cis or trans 19
175	175	tetrahydrocannabinol and their optical isomers. Delta 3, 4 cis or trans tetrahydrocannabinol and 20
176	176	their optical isomer. (Since nomenclature of these substances is not internationally standardized, 21
177	177	compounds of these structures, regardless of numerical designation of atomic positions covered). 22
178	178	(18) Thiophene analog of phencyclidine. 1-(1-(2 thienyl) cyclo-hexyl) pipiridine: 2-23
179	179	Thienyl analog of phencyclidine: TPCP 24
180	180	(19) 2,5 dimethoxyamphetamine 25
181	181	(20) 4 -bromo-2,5-dimethoxyamphetamine, 4 -bromo-2,5-dimethoxy-alpha-26
182	182	methylphenethyamine: 4-bromo-2,5-DMA 27
183	183	(21) 4 -methoxyamphetamine-4-methoxy-alpha-methylphenethylaimine: 28
184	184	paramethoxyamphetamine: PMA 29
185	185	(22) Ethylamine analog of phencyclidine. N-ethyl-1-phenylcyclohexylamine, (1-30
186	186	phenylcyclohexyl) ethylamine, N-(1-phenylcyclophexyl) ethylamine, cyclohexamine, PCE 31
187	187	(23) Pyrrolidine analog of phencyclidine. 1-(1-phencyclohexyl)-pyrrolidine PCPy, PHP 32
188	188	(24) Parahexyl; some trade or other names: 3-Hexyl-1-hydroxy-7,8,9,10-tetrahydro-6,6,9-33
189	189	trimethyl-6H-dibenz o (b,d) pyran: Synhexyl. 34
190	190
191	191
192	192	LC002079 - Page 6 of 18
193	193	(25) Salvia Divinorum (Salvinorin A or Divinorin A), meaning any extract from any part 1
194	194	of the plant, and any compound, salt derivative, or mixture of the plant or its extracts. This shall 2
195	195	not mean the unaltered plant. 3
196	196	(26) Datura stamonium (jimsom weed or datura), meaning any extract from any part of the 4
197	197	plant, and any compound, salt derivative, or mixture of the plant or its extracts. This shall not mean 5
198	198	the unaltered plant. 6
199	199	(e)(d) Depressants. Unless specifically excepted or unless listed in another schedule, any 7
200	200	material, compound, mixture, or preparation that contains any quantity of the following substances 8
201	201	having a depressant effect on the central nervous system, including its salts, isomers, and salts of 9
202	202	isomers whenever the existence of the salts, isomers, and salts of isomers is possible within the 10
203	203	specific chemical designation: 11
204	204	(1) Mecloqualone. 12
205	205	(2) Methaqualone. 13
206	206	(3) 3-methyl fentanyl (n-(3methyl-1(2-phenylethyl)-4-piperidyl)-N-phenylpropanamide. 14
207	207	(4) 3,4-methyl-enedioxymethamphetamine (MDMA), its optical, positional, and geometric 15
208	208	isomers, salts, and salts of isomers. 16
209	209	(5) 1-methyl-4-phenyl-4-propionoxypiperidine (MPPP), its optical isomers, salts, and salts 17
210	210	of isomers. 18
211	211	(6) 1-(2-phenylethyl)-4-phenyl-4-acetyloxypiperidine (PEPAP), its optical isomers, salts, 19
212	212	and salts of isomers. 20
213	213	(7) N -(1-(1-methyl-2-phenyl)ethyl-4-piperidyl)-N-phenyl-acetamide (acetyl-21
214	214	alphamethylfentanyl), its optical isomers, salts, and salts of isomers. 22
215	215	(8) N-(1-(1-methyl-2(2-thienyl)ethyl-4-piperidyl)-N-phenylpropanami de (alpha-23
216	216	methylthiofentanyl), its optical isomers, salts, and salts of isomers. 24
217	217	(9) N-(1-benzyl-piperidyl)-N-phenylpropanamide (benzyl-fentanyl), its optical isomers, 25
218	218	salts, and salts of isomers. 26
219	219	(10) N-(1-(2-hydroxy-2-phenyl)ethyl-4-piperidyl)-N-phenyl-propanamid e (beta-27
220	220	hydroxyfentanyl), its optical isomers, salts, and salts of isomers. 28
221	221	(11) N-(3-methyl-1(2-hydroxy-2-phenyl)ethyl-4-piperidyl)-N-phenylpro panamide (beta-29
222	222	hydroxy-3-methylfentanyl), its optical and geometric isomers, salts, and salts of isomers. 30
223	223	(12) N-(3-methyl)-1-(2-(2-thienyl)ethyl-4-piperidyl)-N-phenylpro-panamide (3-31
224	224	methylthiofentanyl), its optical and geometric isomers, salts, and salts of isomers. 32
225	225	(13) N-(1-2-thienyl)methyl-4-piperidyl)-N-phenylpropanamide (thenylfentanyl), its 33
226	226	optical isomers, salts, and salts of isomers. 34
227	227
228	228
229	229	LC002079 - Page 7 of 18
230	230	(14) N-(1-(2(2-thienyl)ethyl-4-piperidyl-N-phenylpropanamide (thiofentanyl), its optical 1
231	231	isomers, salts, and salts of isomers. 2
232	232	(15) N-[1-(2-phenylethyl)-4-piperidyl]-N-(4-fluorophenyl)-propanamid e (para-3
233	233	fluorofentanyl), its optical isomers, salts, and salts of isomers. 4
234	234	(16) Gamma hydroxybutyrate, HOOC-CH2-CH2-CH2OH, its optical, position, or 5
235	235	geometric isomers, salts, and salts of isomers. 6
236	236	(17) Etizolam. 7
237	237	(18) Flubromazolam. 8
238	238	(f)(e) Stimulants. Unless specifically excepted or unless listed in another schedule, any 9
239	239	material, compound, mixture, or preparation that contains any quantity of the following substances 10
240	240	having a stimulant effect on the central nervous system, including its salts, isomers, and salts of 11
241	241	isomers: 12
242	242	(1) Fenethylline 13
243	243	(2) N-ethylamphetamine 14
244	244	(3) 4-methyl-N-methylcathinone (Other name: mephedrone) 15
245	245	(4) 3,4-methylenedioxy-N-methlycathinone (Other name: methylone) 16
246	246	(5) 3,4-methylenedioxypyrovalerone (Other name: MDPV) 17
247	247	(g) Any material, compound, mixture, or preparation that contains any quantity of the 18
248	248	following substances: 19
249	249	(1) 5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol (CP-47,497) 20
250	250	(2) 5 -(1,1-Dimethyloctyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol 21
251	251	(cannabicyclohexanol and CP-47,497 c8 homologue) 22
252	252	(3) 1-Butyl-3-(1 naphthoyl)indole, (JWH-073) 23
253	253	(4) 1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)indole (JWH-200) 24
254	254	(5) 1-Pentyl-3-(1-napthoyl)indole, (JWH-018 and AM678) 25
255	255	(h)(g) Synthetic cannabinoids or piperazines. Unless specifically excepted, any chemical 26
256	256	compound which is not approved by the United States Food and Drug Administration or, if 27
257	257	approved, which is not dispensed or possessed in accordance with state and federal law, that 28
258	258	contains Benzylpiperazine (BZP); Trifluoromethylphenylpiperazine (TFMPP); 1,1-29
259	259	Dimethylheptyl-11-hydroxytetrahydrocannabinol (HU-210); 1-Butyl-3-(1-naphthoyl) indole; 1-30
260	260	Pentyl-3-(1-naphthoyl) indole; dexanabinol (HU-211); or any compound in the following structural 31
261	261	classes: 32
262	262	(1) Naphthoylindoles: Any compound containing a 3-(1-naphthoyl)indole structure with 33
263	263	substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, alkenyl, 34
264	264
265	265
266	266	LC002079 - Page 8 of 18
267	267	cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl 1
268	268	group, whether or not further substituted in the indole ring to any extent and whether or not 2
269	269	substituted in the naphthyl ring to any extent. Examples of this structural class include, but are not 3
270	270	limited, to JWH-015, JWH-018, JWH-019, JWH-073, JWH-081, JWH-122, JWH-200, and AM-4
271	271	2201; 5
272	272	(2) Phenylacetylindoles: Any compound containing a 3-phenylacetylindole structure with 6
273	273	substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, alkenyl, 7
274	274	cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl 8
275	275	group whether or not further substituted in the indole ring to any extent and whether or not 9
276	276	substituted in the phenyl ring to any extent. Examples of this structural class include, but are not 10
277	277	limited to, JWH-167, JWH-250, JWH-251, and RCS-8; 11
278	278	(3) Benzoylindoles: Any compound containing a 3-(benzoyl) indole structure with 12
279	279	substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, alkenyl, 13
280	280	cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl 14
281	281	group whether or not further substituted in the indole ring to any extent and whether or not 15
282	282	substituted in the phenyl ring to any extent. Examples of this structural class include, but are not 16
283	283	limited, to AM-630, AM-2233, AM-694, Pravadoline (WIN 48,098), and RCS-4; 17
284	284	(4) Cyclohexylphenols: Any compound containing a 2-(3-hydroxycyclohexyl)phenol 18
285	285	structure with substitution at the 5-position of the phenolic ring by an alkyl, haloalkyl, alkenyl, 19
286	286	cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl 20
287	287	group whether or not substituted in the cyclohexyl ring to any extent. Examples of this structural 21
288	288	class include, but are not limited to, CP 47,497 and its C8 homologue (cannabicyclohexanol); 22
289	289	(5) Naphthylmethylindoles: Any compound containing a 1H-indol-3-yl-(1-naphthyl) 23
290	290	methane structure with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, 24
291	291	alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-25
292	292	morpholinyl)ethyl group whether or not further substituted in the indole ring to any extent and 26
293	293	whether or not substituted in the naphthyl ring to any extent. Examples of this structural class 27
294	294	include, but are not limited to, JWH-175, JWH-184, and JWH-185; 28
295	295	(6) Naphthoylpyrroles: Any compound containing a 3-(1-naphthoyl)pyrrole structure with 29
296	296	substitution at the nitrogen atom of the pyrrole ring by an alkyl, haloalkyl, alkenyl, 30
297	297	cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl 31
298	298	group whether or not further substituted in the pyrrole ring to any extent and whether or not 32
299	299	substituted in the naphthyl ring to any extent. Examples of this structural class include, but are not 33
300	300	limited, to JWH-030, JWH-145, JWH-146, JWH-307, and JWH-368; 34
301	301
302	302
303	303	LC002079 - Page 9 of 18
304	304	(7) Naphthylmethylindenes: Any compound containing a 1-(1-naphthylmethyl)indene 1
305	305	structure with substitution at the 3-position of the indene ring by an alkyl, haloalkyl, alkenyl, 2
306	306	cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl 3
307	307	group whether or not further substituted in the indene ring to any extent and whether or not 4
308	308	substituted in the naphthyl ring to any extent. Examples of this structural class include, but are not 5
309	309	limited to, JWH-176; or 6
310	310	(8) Any other synthetic cannabinoid or piperazine which is not approved by the United 7
311	311	States Food and Drug Administration or, if approved, which is not dispensed or possessed in 8
312	312	accordance with state and federal law. 9
313	313	(i) Synthetic cathinones. Unless specifically excepted, any chemical compound which is 10
314	314	not approved by the United States Food and Drug Administration or, if approved, which is not 11
315	315	dispensed or possessed in accordance with state and federal law, not including bupropion, 12
316	316	structurally derived from 2-aminopropan-1-one by substitution at the 1-position with either phenyl, 13
317	317	naphthyl, or thiophene ring systems, whether or not the compound is further modified in one or 14
318	318	more of the following ways: 15
319	319	(1) By substitution in the ring system to any extent with alkyl, alkylenedioxy, alkoxy, 16
320	320	haloalkyl, hydroxyl, or halide substituents, whether or not further substituted in the ring system by 17
321	321	one or more other univalent substituents. Examples of this class include, but are not limited to, 3,4-18
322	322	Methylenedioxycathinone (bk-MDA); 19
323	323	(2) By substitution at the 3-position with an acyclic alkyl substituent. Examples of this 20
324	324	class include, but are not limited to, 2-methylamino-1-phenylbutan-1-one (buphedrone); 21
325	325	(3) By substitution at the 2-amino nitrogen atom with alkyl, dialkyl, benzyl, or 22
326	326	methoxybenzyl groups, or by inclusion of the 2-amino nitrogen atom in a cyclic structure. 23
327	327	Examples of this class include, but are not limited to, Dimethylcathinone, Ethcathinone, and α-24
328	328	Pyrrolidinopropiophenone (α-PPP); or 25
329	329	(4) Any other synthetic cathinone which is not approved by the United States Food and 26
330	330	Drug Administration or, if approved, is not dispensed or possessed in accordance with state or 27
331	331	federal law. Examples of this class include, but are not limited to, Ephylone and Pentylone. 28
332	332	Schedule II 29
333	333	(a) Schedule II shall consist of the drugs and other substances, by whatever official name, 30
334	334	common or usual name, chemical name, or brand name designated, listed in this section. 31
335	335	(b) Substances, vegetable origin, or chemical synthesis. Unless specifically excepted or 32
336	336	unless listed in another schedule, any of the following substances whether produced directly or 33
337	337	indirectly by extraction from substances of vegetable origin, or independently by means of 34
338	338
339	339
340	340	LC002079 - Page 10 of 18
341	341	chemical synthesis, or by a combination of extraction and chemical synthesis: 1
342	342	(1) Opium and opiate, and any salt, compound, derivative, or preparation of opium or 2
343	343	opiate excluding naloxone and its salts, and excluding naltrexone and its salts, but including the 3
344	344	following: 4
345	345	(i) Raw opium 5
346	346	(ii) Opium extracts 6
347	347	(iii) Opium fluid extracts 7
348	348	(iv) Powdered opium 8
349	349	(v) Granulated opium 9
350	350	(vi) Tincture of opium 10
351	351	(vii) Etorphine hydrochloride 11
352	352	(viii) Codeine 12
353	353	(ix) Ethylmorphine 13
354	354	(x) Hydrocodone 14
355	355	(xi) Hydromorphone 15
356	356	(xii) Metopon 16
357	357	(xiii) Morphine 17
358	358	(xiv) Oxycodone 18
359	359	(xv) Oxymorphone 19
360	360	(xvi) Thebaine 20
361	361	(2) Any salt, compound, derivative, or preparation that is chemically equivalent or identical 21
362	362	with any of the substances referred to in subdivision (1) of this subsection, except that these 22
363	363	substances shall not include the isoquinoline alkaloids of opium. 23
364	364	(3) Opium poppy and poppy straw. 24
365	365	(4) Coca leaves and any salt, compound, derivative, or preparation of coca leaves, and any 25
366	366	salt, compound, derivative, or preparation that is chemically equivalent or identical with any of 26
367	367	these substances, except that the substances shall not include decocainized coca leaves or extraction 27
368	368	of coca leaves, which extractions do not contain cocaine or ecgonine. 28
369	369	(5) Concentrate of poppy straw (the crude extract of poppy straw in liquid, solid, or powder 29
370	370	form that contains the phenanthrine alkaloids of the opium poppy). 30
371	371	(c)(b) Opiates. Unless specifically excepted or unless listed in another schedule, any of the 31
372	372	following opiates, including its isomers, esters, ethers, salts; and salts of isomers, esters, and ethers 32
373	373	whenever the existence of the isomers, esters, ethers, and salts is possible within the specific 33
374	374	chemical designation: 34
375	375
376	376
377	377	LC002079 - Page 11 of 18
378	378	(1) Alphaprodine 1
379	379	(2) Anileridine 2
380	380	(3) Bezitramide 3
381	381	(4) Dihydrocodeine 4
382	382	(5) Diphenoxylate 5
383	383	(6) Fentanyl 6
384	384	(7) Isomethadone 7
385	385	(8) Levomethorphan 8
386	386	(9) Levorphanol 9
387	387	(10) Metazocine 10
388	388	(11) Methadone 11
389	389	(12) Methadone-Intermediate, 4-cyano-2-dimethylamino-4, 4-diphenyl butane 12
390	390	(13) Moramide-Intermediate, 2-methyl-3-morpholino-1, 1-diphenylpropane-carboxylic 13
391	391	acid 14
392	392	(14) Pethidine 15
393	393	(15) Pethidine-Intermediate-A, 4-cyano-1-methyl-4-phenylpiperidine 16
394	394	(16) Pethidine-Intermediate-B, ethyl-4-phenylpiperidine-4-carboxylate 17
395	395	(17) Pethidine-Intermediate-C, 1-methyl-4-phenylpiperidine-4-carboxylic acid 18
396	396	(18) Phenaxocine 19
397	397	(19) Piminodine 20
398	398	(20) Racemethorphan 21
399	399	(21) Racemorphan 22
400	400	(22) Bulk Dextropropoxyphene (non-dosage forms) 23
401	401	(23) Suffentanil 24
402	402	(24) Alfentanil 25
403	403	(25) Levoalphacetylmethadol 26
404	404	(26) Carfentanil 27
405	405	(27) Remifentanil 28
406	406	(d)(c) Stimulants. Unless specifically excepted or unless listed in another schedule, any 29
407	407	material, compound, mixture, or preparation that contains any quantity of the following substances 30
408	408	having a stimulant effect on the central nervous system: 31
409	409	(1) Amphetamine, its salts, optical isomers, and salts of its optical isomers. 32
410	410	(2) Methamphetamine, its salts, and salts of its isomers. 33
411	411	(3) Phenmetrazine and its salts. 34
412	412
413	413
414	414	LC002079 - Page 12 of 18
415	415	(4) Methylphenidate. 1
416	416	(e)(d) Depressants. Unless specifically excepted or unless listed in another schedule, any 2
417	417	material, compound, mixture, or preparation that contains any quantity of the following substances 3
418	418	having a depressant effect on the central nervous system, including its salts, isomers, and salts of 4
419	419	isomers whenever the existence of the salts, isomers, and salts of isomers is possible within the 5
420	420	specific chemical designation: 6
421	421	(1) Amobarbital 7
422	422	(2) Glutethimide 8
423	423	(3) Methyprylon 9
424	424	(4) Pentobarbital 10
425	425	(5) Phencyclidine 11
426	426	(6) Secobarbital 12
427	427	(7) Phencyclidine immediate precursors: 13
428	428	(i) 1-phencyclohexylamine 14
429	429	(ii) 1-piperidinocyclohexane-carbonitrile (PCC) 15
430	430	(8) Immediate precursor to amphetamine and methamphetamine: Phenylacetone. Some 16
431	431	other names: phenyl-2-propanone; P2P; benzyl methyl ketone; methyl benzone ketone. 17
432	432	Schedule III 18
433	433	(a) Unless specifically excepted or unless listed in another schedule, any material, 19
434	434	compound, mixture, or preparation that contains any quantity of the following substances having a 20
435	435	depressant effect on the central nervous system: 21
436	436	(1) Any substance that contains any quantity of a derivative of barbituric acid or any salt 22
437	437	of a derivative of barbituric acid. 23
438	438	(2) Chlorhexadol 24
439	439	(3) Lysergic acid 25
440	440	(4) Lysergic acid amide 26
441	441	(5) Sulfondiethylmethane 27
442	442	(6) Sulfonethylmethane 28
443	443	(7) Sylfonmethane 29
444	444	(8) Any compound, mixture, or preparation containing amobarbital, secobarbital, 30
445	445	pentobarbital, or any salt of them and one or more other active medicinal ingredients that are not 31
446	446	listed in any schedule. 32
447	447	(9) Any suppository dosage form containing amobarbital, secobarbital, pentobarbital, or 33
448	448	any salt of any of these drugs and approved by the Food and Drug Administration for marketing 34
449	449
450	450
451	451	LC002079 - Page 13 of 18
452	452	only as a suppository. 1
453	453	(10) Ketamine, its salts, isomers, and salts of isomers. (Some other names for ketamine: 2
454	454	(+)-2-(2-chlorophenyl)-2-(methylamino)-cyclohexanone). 3
455	455	(b) Unless specifically excepted or unless listed in another schedule, any material, 4
456	456	compound, mixture, or preparation containing limited quantities of any of the following narcotic 5
457	457	drugs, or any salts of them: 6
458	458	(1) Not more than one and eight tenths grams (1.8 gms.) of codeine per one hundred 7
459	459	milliliters (100 mls.) or not more than ninety milligrams (90 mgs.) per dosage unit, with an equal 8
460	460	or greater quantity of an isoquinoline alkaloid of opium. 9
461	461	(2) Not more than one and eight tenths grams (1.8 gms.) of codeine per one hundred 10
462	462	milliliters (100 mls.) or not more than ninety milligrams (90 mgs.) per dosage unit, with one or 11
463	463	more active, nonnarcotic ingredients in recognized therapeutic amounts. 12
464	464	(3) Not more than three hundred milligrams (300 mgs.) of dihydrocodeinone per one 13
465	465	hundred milliliters (100 mls.) or not more than fifteen milligrams (15 mgs.) per dosage unit, with 14
466	466	a fourfold or greater quantity of an isoquinoline alkaloid of opium. 15
467	467	(4) Not more than three hundred milligrams (300 mgs.) of dihydrocodeinone per one 16
468	468	hundred milliliters (100 mls.) or not more than fifteen milligrams (15 mgs.) per dosage unit, with 17
469	469	one or more active nonnarcotic ingredients in recognized therapeutic amounts. 18
470	470	(5) Not more than one and eight tenths grams (1.8 gms.) of dihydrocodeine per one hundred 19
471	471	milliliters (100 mls.) or not more than ninety milligrams (90 mgs.) per dosage unit, with one or 20
472	472	more active nonnarcotic ingredients in recognized therapeutic amounts. 21
473	473	(6) Not more than three hundred milligrams (300 mgs.) of ethylmorphine per one hundred 22
474	474	milliliters (100 mls.) or not more than fifteen milligrams (15 mgs.) per dosage unit, with one or 23
475	475	more active nonnarcotic ingredients in recognized therapeutic amounts. 24
476	476	(7) Not more than five hundred milligrams (500 mgs.) of opium per one hundred milliliters 25
477	477	(100 mls.) or per one hundred grams (100 gms.) or not more than twenty-five milligrams (25 mgs.) 26
478	478	per dosage unit, with one or more active nonnarcotic ingredients in recognized therapeutic amounts. 27
479	479	(8) Not more than fifty milligrams (50 mgs.) of morphine per one hundred milliliters (100 28
480	480	mls.) per one hundred grams (100 gms.) with one or more active, nonnarcotic ingredients in 29
481	481	recognized therapeutic amounts. 30
482	482	(c) Stimulants. Unless specifically excepted or listed in another schedule, any material, 31
483	483	compound, mixture, or preparation that contains any quantity of the following substances having a 32
484	484	stimulant effect on the central nervous system, including its salts, isomers, and salts of the isomers 33
485	485	whenever the existence of the salts of isomers is possible within the specific chemical designation: 34
486	486
487	487
488	488	LC002079 - Page 14 of 18
489	489	(1) Benzphetamine 1
490	490	(2) Chlorphentermine 2
491	491	(3) Clortermine 3
492	492	(4) Mazindol 4
493	493	(5) Phendimetrazine 5
494	494	(d) Steroids and hormones. Anabolic steroids (AS) or human growth hormone (HGH), 6
495	495	excluding those compounds, mixtures, or preparations containing an anabolic steroid that because 7
496	496	of its concentration, preparation, mixture, or delivery system, has no significant potential for abuse, 8
497	497	as published in 21 C.F.R. § 1308.34, including, but not limited to, the following: 9
498	498	(1) Chorionic gonadotropin, except for veterinary use and when that use is approved by the 10
499	499	Food and Drug Administration. 11
500	500	(2) Clostebol 12
501	501	(3) Dehydrochlormethyltestosterone 13
502	502	(4) Ethylestrenol 14
503	503	(5) Fluoxymesterone 15
504	504	(6) Mesterolone 16
505	505	(7) Metenolone 17
506	506	(8) Methandienone 18
507	507	(9) Methandrostenolone 19
508	508	(10) Methyltestosterone 20
509	509	(11) Nandrolone decanoate 21
510	510	(12) Nandrolone phenpropionate 22
511	511	(13) Norethandrolone 23
512	512	(14) Oxandrolone 24
513	513	(15) Oxymesterone 25
514	514	(16) Oxymetholone 26
515	515	(17) Stanozolol 27
516	516	(18) Testosterone propionate 28
517	517	(19) Testosterone-like related compounds 29
518	518	(20) Human Growth Hormone (HGH) 30
519	519	(e) Hallucinogenic substances. 31
520	520	(1) Dronabinol (synthetic) in sesame oil and encapsulated in a soft gelatin capsule in U.S. 32
521	521	Food and Drug Administration-approved drug product. (Some other names for dronabinol: (6aR-33
522	522	trans)-6a, 7, 8, 10a-tetrahydro-6, 6, 9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol, or (-)-delta-34
523	523
524	524
525	525	LC002079 - Page 15 of 18
526	526	9(trans)-tetrahydrocannabinol.) 1
527	527	Schedule IV 2
528	528	(1) Barbital. 3
529	529	(2) Chloral betaine 4
530	530	(3) Chloral hydrate 5
531	531	(4) Ethchrovynol 6
532	532	(5) Ethinamate 7
533	533	(6) Methohexital 8
534	534	(7) Meprobamate 9
535	535	(8) Methylphenobarbital 10
536	536	(9) Paraldehyde 11
537	537	(10) Petrichloral 12
538	538	(11) Phenobarbital 13
539	539	(12) Fenfluramine 14
540	540	(13) Diethylpropion 15
541	541	(14) Phentermine 16
542	542	(15) Pemoline (including organometallic complexes and chelates thereof). 17
543	543	(16) Chlordiazepoxide 18
544	544	(17) Clonazepam 19
545	545	(18) Clorazepate 20
546	546	(19) Diazepam 21
547	547	(20) Flurazepam 22
548	548	(21) Mebutamate 23
549	549	(22) Oxazepam 24
550	550	(23) Unless specifically excepted or unless listed in another schedule, any material, 25
551	551	compound, mixture, or preparation that contains any quantity of the following substances, including 26
552	552	its salts: 27
553	553	Dextropropoxyphene(alpha-(+)-4-dimethylamino-1,2-diphenyl-3-methyl-2-propronox 28
554	554	ybutane). 29
555	555	(24) Prazepam 30
556	556	(25) Lorazepam 31
557	557	(26) Not more than one milligram (1 mg.) of difenoxin and not less than twenty-five (25) 32
558	558	micrograms of atropine sulfate per dosage unit. 33
559	559	(27) Pentazocine 34
560	560
561	561
562	562	LC002079 - Page 16 of 18
563	563	(28) Pipradrol 1
564	564	(29) SPA (-)-1-dimethylamino-1, 2-diphenylethane 2
565	565	(30) Temazepam 3
566	566	(31) Halazepam 4
567	567	(32) Alprazolam 5
568	568	(33) Bromazepam 6
569	569	(34) Camazepam 7
570	570	(35) Clobazam 8
571	571	(36) Clotiazepam 9
572	572	(37) Cloxazolam 10
573	573	(38) Delorazepam 11
574	574	(39) Estazolam 12
575	575	(40) Ethyl Ioflazepate 13
576	576	(41) Fludizaepam 14
577	577	(42) Flunitrazepam 15
578	578	(43) Haloxazolam 16
579	579	(44) Ketazolam 17
580	580	(45) Loprazolam 18
581	581	(46) Lormetazepam 19
582	582	(47) Medazepam 20
583	583	(48) Nimetazepam 21
584	584	(49) Nitrazepam 22
585	585	(50) Nordiazepam 23
586	586	(51) Oxazolam 24
587	587	(52) Pinazepam 25
588	588	(53) Tetrazepam 26
589	589	(54) Mazindol 27
590	590	(55) Triazolam 28
591	591	(56) Midazolam 29
592	592	(57) Quazepam 30
593	593	(58) Butorphanol 31
594	594	(59) Sibutramine 32
595	595	(60) Tramadol 33
596	596	(61) Zolpidem 34
597	597
598	598
599	599	LC002079 - Page 17 of 18
600	600	Schedule V 1
601	601	(a) Any compound, mixture, or preparation containing any of the following limited 2
602	602	quantities of narcotic drugs, which shall include one or more non-narcotic active medicinal 3
603	603	ingredients in sufficient proportion to confer upon the compound, mixture, or preparation valuable 4
604	604	medicinal qualities other than those possessed by the narcotic drug alone: 5
605	605	(1) Not more than two hundred milligrams (200 mgs.) of codeine per 100 milliliters (100 6
606	606	mls.) or per one hundred grams (100 gms.). 7
607	607	(2) Not more than one hundred milligrams (100 mgs.) of dihydrocodeine per 100 milliliters 8
608	608	(100 mls.) or per one hundred grams (100 gms.). 9
609	609	(3) Not more than one hundred milligrams (100 mgs.) of ethylmorphine per 100 milliliters 10
610	610	(100 mls.) or per one hundred grams (100 gms.). 11
611	611	(4) Not more than two and five tenths milligrams (2.5 mgs.) of diphenixylate and not less 12
612	612	than twenty-five (25) micrograms of atropine sulfate per dosage unit. 13
613	613	(5) Not more than one hundred milligrams (100 mgs.) of opium per one hundred milliliters 14
614	614	(100 mls.) or per one hundred grams (100 gms.). 15
615	615	(b) Not more than five tenths milligrams (0.5 mgs.) of difenoxin and not less than twenty-16
616	616	five (25) micrograms of atropine sulfate per dosage unit. 17
617	617	(c) Buprenorphine 18
618	618	(d) Unless specifically exempted or excluded or unless listed in another schedule, any 19
619	619	material, compound, mixture, or preparation that contains any quantity of the following substances 20
620	620	having a stimulant effect on the central nervous system, including its salts, isomers, and salts of 21
621	621	isomers: 22
622	622	(1) Propylhexedrine (except as benzedrex inhaler) 23
623	623	(2) Pyrovalerone. 24
624	624	(e) Xylazine HCL 25
625	625	SECTION 2. This act shall take effect upon passage. 26
626	626	========
627	627	LC002079
628	628	========
629	629
630	630
631	631	LC002079 - Page 18 of 18
632	632	EXPLANATION
633	633	BY THE LEGISLATIVE COUNCIL
634	634	OF
635	635	A N A C T
636	636	RELATING TO FOOD AND DRUGS -- UNIFORM CONTROLLED S UBSTANCES ACT
637	637	***
638	638	This act would provide that Schedules I through V of the Uniform Controlled Substances 1
639	639	Act consist of drugs and other substances, by whatever official name, common or usual name, 2
640	640	chemical name or name designated by the director of the department of health, and would add 3
641	641	several new drugs to various schedules, including Etizolam, Flubromazolam, Tramadol, Zolpidem, 4
642	642	and Xylazine HCL. 5
643	643	This act would take effect upon passage. 6
644	644	========
645	645	LC002079
646	646	========